Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Northernvinceon Aug 01, 2020 10:33pm
226 Views
Post# 31354755

🔥🔥🔥WHY $QSC🔥🔥🔥

🔥🔥🔥WHY $QSC🔥🔥🔥REFRESH $QSC -One of the 12 lateral flow test kit(10-15 min result covid 19) that have received the Emergency Use Autorisation by the FDA... -Best antibody test on the market coz of their technologie: coloidal gold (GOLD NANOPARTICULE in fluid)...yes gold nonaparticule!!! -Ceo director have many years of experience and connexions with biotech and big pharma... - they already submited application for point of care (poc) (waiting for approval) wich will allow them to partner with "cvs" and other major drug store as well... -partnership in place with professional sport teams... -clinical study : 2430 clinical patients tested - sensitivity: 100% specitivity: 98.8% -expected sale: 4 millions test by months 25$US/test... -North america exclusivity and solid print in south america... - Low MC (19 millions$) -Low float stock (90 millions shares) - still under the radar -Last webinar: https://questcapinc.com/questcap-corporate-update-investor-webinar-june-2020/ Worth a full watch but you can go straight to 40 min... -Last NR: https://ceo.ca/@nasdaq/questcap-secures-exclusive-sales-rights-for-emergency -Ceo director background: https://questcapinc.com/qc_team/doug-sommerville/ Connect the dots... GLTA !!!
<< Previous
Bullboard Posts
Next >>